文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.

作者信息

Ben-Baruch Adit

机构信息

The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.

出版信息

Front Immunol. 2022 May 18;13:903679. doi: 10.3389/fimmu.2022.903679. eCollection 2022.

DOI:10.3389/fimmu.2022.903679
PMID:35663982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9157545/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/9157545/ec825cc266db/fimmu-13-903679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/9157545/ec825cc266db/fimmu-13-903679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb0e/9157545/ec825cc266db/fimmu-13-903679-g001.jpg

相似文献

[1]
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy.

Front Immunol. 2022-5-18

[2]
Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2.

Arthritis Res Ther. 2012-10-18

[3]
Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4Foxp3 induced Treg cells in vitro and in vivo periphery in autoimmune diseases.

Cell Death Dis. 2019-1-10

[4]
TNFR1 and TNFR2 signaling interplay in cardiac myocytes.

J Biol Chem. 2007-12-7

[5]
Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion.

J Neurosci. 2004-10-27

[6]
Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.

Am J Physiol Renal Physiol. 2001-5

[7]
Tumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2.

PLoS One. 2013-5-21

[8]
Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.

Reprod Sci. 2014-5-20

[9]
Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats.

Am J Pathol. 2009-7

[10]
Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.

Front Immunol. 2018-4-19

引用本文的文献

[1]
Probiotic, antimicrobial and anticancer properties of Lysinibacillus macroides, Kurthia huakuii, and Enterococcus faecium isolated from freshwater snail gut microbiota.

BMC Biotechnol. 2025-9-3

[2]
Advancing health psychology research in oncology: Biobehavioral models, stress pathways, and stress-management interventions for cancer patients.

Int J Clin Health Psychol. 2025

[3]
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System.

Int J Mol Sci. 2025-7-16

[4]
Tumor Necrosis Factor-Alpha's Role in the Pathophysiology of Colon Cancer.

Diseases. 2025-6-15

[5]
Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model.

Immunotherapy. 2025-4

[6]
Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study.

Biomedicines. 2025-4-9

[7]
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors.

Mol Ther. 2025-2-5

[8]
Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans.

J Biol Chem. 2025-1

[9]
Chemotherapy combined with Shenmai injection alleviates inflammatory response and side effects in the patients with advanced colorectal cancer: A retrospective analysis.

Pak J Med Sci. 2024-10

[10]
Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment.

Front Immunol. 2024-8-14

本文引用的文献

[1]
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors.

J Immunother Cancer. 2022-3

[2]
Harnessing cytokines and chemokines for cancer therapy.

Nat Rev Clin Oncol. 2022-4

[3]
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.

Int Immunopharmacol. 2021-12

[4]
The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.

Int J Cancer. 2022-4-15

[5]
Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice.

Rheumatology (Oxford). 2022-5-5

[6]
Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors.

Cells. 2021-6-8

[7]
Utilizing Immunocytokines for Cancer Therapy.

Antibodies (Basel). 2021-3-9

[8]
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy.

Front Oncol. 2021-1-26

[9]
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.

Rheumatology (Oxford). 2021-8-2

[10]
Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer.

Neoplasia. 2021-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索